retatrutide glp-1 gip glucagon agonist The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a triple agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Retatrutide Explained: The Triple Agonist

Results from ongoing and future studies of the once-daily danuglipron modified release formulation will inform a potential path forward to improve the tolerability profile and optimize both study design and execution, Mikael Dolsten, Pfizer CSO and president of research and development, said in a statement

It is a molecule composed of three amino acidsglycine, cysteine, and glutamine

FRIDAY, May 23, 2025 (HealthDay News) A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on

A few developments had occurred in the software & AI space that I had not anticipated, and rather than continue to take such a granular view into what I expected would be continued market strength, it seemed prudent to have our net exposure higher and not take more risk than necessary on long/short AI until the trend had played out further

This method increases the bioavailability because the mixture reaches the stomach at the correct pH level required for effective absorption